VistaGen Therapeutics
VTGN
$4.66
Share price
0.87%
Change (1 day)
3,484.62%
Change (1 year)
Categories
VistaGen Therapeutics (VTGN) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $7.78 M
According to VistaGen Therapeutics 's latest financial reports the company's total liabilities are $7.78 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
VistaGen Therapeutics - Total liabilities on balance sheet (from 2008 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-03-31 | $9 M | -9.26% |
| 2022-03-31 | $9.92 M | -39.1% |
| 2021-03-31 | $16.3 M | 41.74% |
| 2020-03-31 | $11.5 M | 65.81% |
| 2019-03-31 | $6.93 M | 59.03% |
| 2018-03-31 | $4.36 M | 40.86% |
| 2017-03-31 | $3.09 M | -21.95% |
| 2016-03-31 | $3.96 M | -80.94% |
| 2015-03-31 | $20.81 M | 59.32% |
| 2014-03-31 | $13.06 M | -2.79% |
| 2013-03-31 | $13.43 M | 122.22% |
| 2012-03-31 | $6.04 M | |
| 2010-12-31 | $0 M | 113.33% |
| 2009-12-31 | $0 M | -44.15% |
| 2008-12-31 | $0 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | 258.71% | 🇺🇸 USA |